Provided is a new anti-cancer agent lower in cell toxicity.
The present invention provides the compounds represented by the general
formula of "Formula 1" or the salt thereof. The compounds are compounds
having an organic group introduced on a particular ketone group of VST
that functions to inhibit induction of GRP 78 expression, similarly to
VST, and is applicable, for example, as an anti-cancer agent. The
compounds are also advantageous in that it is less toxic than VST and has
lower adverse reaction.
##STR00001##